«Age - old malaria treatment found to
improve nanoparticle delivery to tumors: Nanomedicine researchers find new use for 70 - year - old drug.»
Not exact matches
A
nanoparticle drug -
delivery system that combines two complementary types of anticancer treatment could
improve outcomes for patients with pancreatic cancer and other highly treatment - resistant tumors while decreasing toxicity.
While on one hand, there is significant potential in the application of
nanoparticles in enhancing heat transfer for tumor ablation and targeted drug
delivery, there is also much promise in
improving imaging and diagnostic protocols using them.
And a few different techniques have since emerged to
improve drug
delivery, and, by extension, safety — such as Alnylam's approach of binding the RNAi therapeutic to a lipid
nanoparticle, or fat, to help it settle in the liver.
Drug
delivery systems (DDS) such as lipid - or polymer - based
nanoparticles can be designed to
improve the pharmacological and therapeutic properties of drugs administered parenterally.
Using chloroquine, the researchers not only increased the circulation of
nanoparticles in the body, but also reduced the body's filtration of
nanoparticles, as well as
improved drug
delivery to breast tumors.
The growing trend to use other types of
nanoparticles has revolutionized the food industry by enhancing flavors,
improving supplement
delivery, keeping food fresh longer and brightening the colors of food.
Prior studies suggested that
nanoparticle drug
delivery might
improve the therapeutic response to anticancer drugs and allow the simultaneous monitoring of drug uptake by tumors.
To
improve the therapeutic window of STING agonist, iTeos selected Cristal Therapeutics
nanoparticle technology to control the
delivery towards the tumor microenvironment.
We've seen drugs capable of turning white fat - storing tissue into brown, fat - burning tissue, but a new
nanoparticle delivery system could significantly
improve how such treatments are delivered, avoiding unwanted side effects often associated with such therapy.
But administering curcumin using a different pharmaceutical
delivery system, solid lipid
nanoparticles (SLN),
improves its stability and lengthens its time of release, resulting in better skin penetration.